| Dr Richard Mark Lachiver, MD, MPH | |
|
1860 Westbury Ct, Brentwood, TN 37027-8148 | |
| (615) 372-3508 | |
| (615) 372-3640 |
| Full Name | Dr Richard Mark Lachiver |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 1860 Westbury Ct, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548373152 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 39334 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Mark Lachiver, MD, MPH 1860 Westbury Ct, Brentwood, TN 37027-8148 Ph: () - | Dr Richard Mark Lachiver, MD, MPH 1860 Westbury Ct, Brentwood, TN 37027-8148 Ph: (615) 372-3508 |
News Archive
The Fort Worth Star-Telegram's "recent series on HIV/AIDS accuses [black clergy] of being unaware, inert and unconcerned about the AIDS pandemic" and did not note a "very important truth: The church is changing in response to this challenge, and people of faith are making a difference," Valda Jean Combs, a local pastor who heads the FullProof HIV Ministry, writes in a Star-Telegram opinion piece.
UCSF researchers have found that examining levels of antiretroviral drugs in hair samples taken from HIV patients on therapy strongly predicts treatment success.
When it comes to early diagnosis of Lyme disease, the insidious tick-borne illness that afflicts about 300,000 Americans annually, finding the proverbial needle in the haystack might be a far easier challenge-until now, perhaps. An experimental method developed by federal and university researchers appears capable of detecting the stealthy culprit Lyme bacteria at the earliest time of infection, when currently available tests are often still negative.
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.
› Verified 3 days ago
Perry Anthony Chapdelaine Jr., MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 229 Ward Circle, Suite B12, Brentwood, TN 37027 Phone: 615-377-6767 Fax: 615-377-6768 | |
Dr. David Meadow Ferriss Jr., MD, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 481 Sterns Xing, Brentwood, TN 37027 Phone: 615-260-4958 | |
Dr. Richard Vatt, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5301 Virginia Way, Suite 200, Brentwood, TN 37027 Phone: 630-263-3050 | |
Oluyomi Faparusi Sr., M.D., J.D., PH.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1274 Wheatley Forest Dr, Brentwood, TN 37027 Phone: 410-375-9817 | |
Robin Richard, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9114 Brentmeade Blvd, Brentwood, TN 37027 Phone: 615-370-5907 |